Advertisement
Screener

NORTHWEST BIOTHERAPEUTICS INC (NWBO) Stock Issued During Period, Value, New Issues

NORTHWEST BIOTHERAPEUTICS INC Stock Issued During Period, Value, New Issues

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, new issues for the quarter ending 2026-06-30 was $104.00K, a 98.58% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, new issues for the quarter ending 2026-03-31 was $2.90M, a 43.39% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, new issues for the quarter ending 2025-12-31 was $2.02M, a 49.70% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, new issues for the quarter ending 2025-09-30 was $4.86M, a 31.66% decline year-over-year.
  • NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, new issues for fiscal 2025 was $19.32M, a 37.83% increase from fiscal 2024.
  • NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, new issues for fiscal 2024 was $14.02M.
  • NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, new issues for fiscal 2015 was $81.66M.
  • NORTHWEST BIOTHERAPEUTICS INC stock issued during period, value, new issues for fiscal 2013 was $77.51M, a 28.91% increase from fiscal 2012.
Period endStock Issued During Period, Value, New Issues 3 monthStock Issued During Period, Value, New Issues 12 month
2026-06-30$104.00K
10-Q · filed 2026-08-14
$9.88M
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$2.90M
10-Q · filed 2026-05-15
$17.10M
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$2.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$19.32M
10-K · filed 2026-04-15
2025-09-30$4.86M
10-Q · filed 2025-11-14
$21.31M
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$7.32M
10-Q · filed 2026-08-14
$23.56M
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31$5.12M
10-Q · filed 2026-05-15
$19.14M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$4.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$14.02M
10-K · filed 2026-04-15
2024-09-30$7.11M
10-Q · filed 2025-11-14
2024-06-30$2.90M
10-Q · filed 2025-08-14
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
2022-06-30$6.33M
10-Q · filed 2022-08-09
2022-03-31$3.36M
10-Q · filed 2023-05-10
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
2021-03-31$16.00K
10-Q · filed 2022-05-10
2015-12-31$41.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-17
$81.66M
10-K · filed 2017-04-17
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
2015-06-30$36.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
2015-03-31$3.65M
10-Q · filed 2015-05-11
2013-12-31$38.10M
10-K · filed 2014-04-01
$77.51M
10-K · filed 2014-04-01
2013-09-30$24.79M
10-K · filed 2014-04-01
$76.50M
derived: sum of 4 quarters · filed 2016-03-16
2013-06-30$900.00K
10-K · filed 2016-03-16
$56.93M
derived: sum of 4 quarters · filed 2016-03-16
2013-03-31$900.00K
10-K · filed 2016-03-16
$57.17M
derived: sum of 4 quarters · filed 2016-03-16
2012-12-31$49.92M
10-K · filed 2014-04-01
$60.13M
10-K · filed 2014-04-01
2012-09-30$5.21M
10-K · filed 2014-04-01
$29.02M
derived: sum of 4 quarters · filed 2014-04-01
2012-06-30$1.14M
10-K · filed 2014-04-01
$25.19M
derived: sum of 4 quarters · filed 2014-04-01
2012-03-31$3.85M
10-K · filed 2014-04-01
$30.94M
derived: sum of 4 quarters · filed 2014-04-01
2011-12-31$18.81M
10-K · filed 2013-04-08
$32.48M
10-K · filed 2013-04-08
2011-09-30$1.39M
10-K · filed 2013-04-08
2011-06-30$6.89M
10-K · filed 2013-04-08
2011-03-31$5.39M
10-K · filed 2013-04-08
2002-12-31$200.00K
10-K · filed 2012-04-13